Clinical trial · Observational
Metabolism Des LAM
Rôle Pronostique Des métabolismes du Stress Oxydatif et du Fer Dans Les Leucémies Aiguës Myéloblastiques
NCT02176109CI-TRIAL-00014949LAM-ROSunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this study, the investigators study the prognostic role of oxidative stress metabolism and iron in Acute myeloid leukemia.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Myeloid Leukemia | Acute Myeloid Leukemia | CURATED_BROADER | 0.80 |
| Diagnosis | — | UNRESOLVED | — |
| Iron | — | UNRESOLVED | — |
| Oxydative Stress | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- overall survival Event-free survival Response to induction chemotherapy, overalll survival, event-free survival
- timeFrame
- five years after the inclusion
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: de novo acute myeloid leukemic patient from 18 years to 99 years at diagnosis Exclusion Criteria: age under 18 years promelocytic leukemia secondary leukemia
References
Publications (0)
Data not yet available
No reference posted for this study.